Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Neoplasms 3Osteosarcoma 2Triple Negative Breast Neoplasms 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Pathologic Complete Response 1Ovarian Carcinosarcoma 1Neuroblastoma 1Neoplasm Metastasis 1Melanoma 1Hodgkin Disease 1Hepatoblastoma 1Hemangiosarcoma 1Glioblastoma 1Fibrolamellar hepatocellular carcinoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Carcinoma, Neuroendocrine 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adrenocortical Carcinoma 1

Interventions

Cyclophosphamide 42fludarabine phosphate 33Peripheral Blood Stem Cell Transplantation 32Mycophenolic Acid 26Whole-Body Irradiation 23Cyclosporine 23Busulfan 23Radiotherapy 19Filgrastim 19Antilymphocyte Serum 19Tacrolimus 16Melphalan 16Methotrexate 12Methylprednisolone 10Cord Blood Stem Cell Transplantation 10Etoposide 8Thiotepa 6sargramostim 5fludarabine 5Therapeutics 5aldesleukin 4Sirolimus 4Cytarabine 4Polymerase Chain Reaction 3Paclitaxel 3Granulocyte Colony-Stimulating Factor 3Carmustine 3Amplified Fragment Length Polymorphism Analysis 3Alemtuzumab 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × dostarlimab × Sarcoma × Clear all
NCT06521567 2025-11-12

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

GlaxoSmithKline

Phase 1/2 Active not recruiting
83 enrolled
CNSDermatologicGastrointestinalLymphoidSarcoma

Fibrolamellar hepatocellular carcinoma, Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Melanoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡